Ember-4: A Phase 3 Adjuvant Trial Of Imlunestrant Vs Standard Endocrine Therapy (Et) In Patients With Er+, Her2- Early Breast Cancer (Ebc) With An Increased Risk Of Recurrence Who Have Previously Received 2 To 5 Years Of Adjuvant Et
Imlunestrant
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Ember-4: A Phase 3 Adjuvant Trial Of Imlunestrant Vs Standard Endocrine Therapy (Et) In Patients With Er+, Her2- Early Breast Cancer (Ebc) With An Increased Risk Of Recurrence Who Have Previously Received 2 To 5 Years Of Adjuvant Et ### Output: Imlunestrant